HIV

The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

Doctor communicating with patient | Image credit: bongkarn - stock.adobe.com
People Living With HIV Communicate Less With Health Care Providers

June 9th 2025

About 40% of people living with HIV in an international survey did not make joint decisions regarding treatment with their provider despite reporting a high amount of trust.

Machine learning | Image credit: putilov_denis - stock.adobe.com
Machine Learning Capable of Predicting Hyperlipidemia in People With HIV

May 28th 2025

Young adult HIV | Image credit: ViDi Studio - stock.adobe.com
Adolescents, Young Adults With HIV at Increased Risk of Mental Health Issues

May 20th 2025

HIV | Image credit: RAJCREATIONZS - stock.adobe.com
Implementation of HIV Molecular Cluster Detection in US

May 15th 2025

Tuberculosis | Image credit: Dr_Microbe - stock.adobe.com
ART, Tuberculosis Prevention Treatments Effective When Taken Simultaneously

May 14th 2025

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.
Continuing Medical Education
View All
June 10th 2025

Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence

1.5 Credits / HIV/AIDS, Infectious Diseases

More News

WWR banner
March 6th 2024

What We’re Reading: COVID-19 Test Program End; Ozempic Lowers Liver Disease Risk; Amniotic Fluid Cells, Organ Growth

AJMC Staff
The US government’s program to send free COVID-19 tests is ending later this week; a new study found that Ozempic (semaglutide) may lower liver disease risks in people living with HIV; scientists use cells from amniotic fluid to grow miniature organs.
Nurse talking to patient | Image credit: rocketclips - stock.adobe.com
March 5th 2024

Blood Pressure, Cholesterol Lowered in People Living With HIV Using Nurse-Led Strategy

Julia Bonavitacola
A nurse-led strategy for people living with HIV was able to reduce both blood pressure and cholesterol in a 12-month period.
HIV Virus | Image credit: RAJCREATIONZS - stock.adobe.com
February 28th 2024

Patients With HIV, PH Had Higher Burden of Comorbidities

Julia Bonavitacola
The higher burden of comorbidities in patients with both HIV and pulmonary hypertension (PH) led to worse outcomes, including mortality.
Blue FDA Approved stamp on white surface | Image credit: Olivier Le Moal - stock.adobe.com
February 26th 2024

Bictegravir Receives Expanded Indication by FDA to Treat HIV

Julia Bonavitacola
Patients with HIV who have suppressed viral loads and pre-existing resistance will be able to use bictegravir with this FDA approval.
Human brain | Image credit: Siarhei - stock.adobe.com
February 19th 2024

Adults With Intellectual, Developmental Disabilities at Risk for Disparities in HIV

Julia Bonavitacola
Different levels of risk for HIV exist in the different subtypes of intellectual and developmental disabilities.
Close-up of vaccine | Image credit: weyo - stock.adobe.com
February 15th 2024

Vaccine Confidence in Pregnant Women Living With HIV Requires Further Study

Julia Bonavitacola
Pregnant women who are living with HIV are underrepresented in studies on the efficacy of vaccines, leading to difficult policy decisions for this population.
Woman holding HIV ribbon | Image credit: fizkes - stock.adobe.com
February 6th 2024

Continuity of HIV Care Preserved During Pandemic Through Telemedicine, Despite Lack of In-Person Care

Julia Bonavitacola
Strategies used during the COVID-19 pandemic to ensure continuity of care in people living with HIV can be used as a paradigm of adaptability during unexpected crises.
Bottle of prescription opioids | Image credit: Kimberly Boyles - stock.adobe.com
February 2nd 2024

OUD Stable Over Time in People Living With HIV, Chronic Pain

Julia Bonavitacola
Although rates of opioid use disorder (OUD) are higher than previous estimates, OUD was relatively stable or decreasing over time in patients with HIV.
Man with face in hands | Image credit: ARAMYAN - stock.adobe.com
January 23rd 2024

Internalized HIV Stigma, Depressive Symptoms Linked in People Living With HIV

Julia Bonavitacola
People living with HIV reported feeling inferiority due to HIV and gloomy feelings during the COVID-19 pandemic, as researchers linked internalized HIV stigma to depressive symptoms.
Machine learning | Image credit: WrightStudio - stock.adobe.com
January 23rd 2024

Machine Learning Effective in Predicting Hospital Stay, Prolonged Hospitalization in People Living With HIV

Julia Bonavitacola
Separate machine learning models were able to effectively predict both the length of hospital stay and the risk of prolonged hospitalization in people living with HIV.
Medical syringe with vaccine | Image credit: weyo - stock.adobe.com
January 17th 2024

Vaccination for Hepatitis A Low in People Living With HIV

Julia Bonavitacola
Patients living with HIV had a lower uptake of hepatitis A virus vaccination despite it being recommended for this population.
HIV Virus | Image credit: artegorov3@gmail - stock.adobe.com
January 11th 2024

Women Living With HIV Could Have Tooth Loss After Menopause

Julia Bonavitacola
The deterioration of bones could contribute to the loss of teeth in women who are postmenopausal and living with HIV.
breast cancer awareness ribbon | Image credit: NaMong Productions - stock.adobe.com
December 25th 2023

Patients With Breast Cancer, HIV More Likely to Experience Suboptimal Adjuvant Chemotherapy Delivery

Brooke McCormick
The researchers noted the need for strategies to better support women living with HIV with breast cancer during toxic therapies to improve outcomes among this growing population.
Top 5 Most-Read HIV Articles of 2023
December 20th 2023

Top 5 Most-Read HIV Articles of 2023

Julia Bonavitacola
The top-read topics in HIV for 2023 included dried blood tests for HIV, people with HIV facing stigmas, and vitamin D supplementation in women with HIV.
Top 5 Most-Read News Content of 2023
December 18th 2023

Top 5 Most-Read News Content of 2023

Julia Bonavitacola
The top 5 most-read news content for 2023 featured COVID-19 vaccination uptake and its relation to HIV viral suppression, those more likely to get vitamin D supplements, and recurrence of Clostridioides difficile infection.
Patient with HIV | Image credit: fizkes - stock.adobe.com
December 13th 2023

All-Cause Mortality of Chinese Patients With HIV Declined During Past Decade, Study Says

Brooke McCormick
From 2013 to 2022, the all-cause mortality rate among patients with HIV in China declined from 5.4% to 2.7%.
newborn | Image credit: Anatta_Tan - stock.adobe.com
December 11th 2023

HIV-Infected Infants Treated Within Hours of Birth Attain, Sustain Undetectable Virus

Kenneth Bender, PharmD, MA
Infants with HIV could be spared from requiring lifetime antiretroviral (ART) if treated within hours of birth to disrupt formation of HIV viral reservoirs.
what we're reading
December 7th 2023

What We’re Reading: AIDS Relief Negotiations; Menthol Cigarette Ban Delayed; At-Home Flu, COVID-19 Testing

AJMC Staff
Negotiations to extend US global HIV/AIDS relief work are deadlocked; the Biden administration delayed its rule on the proposed menthol cigarette ban until March 2024 after lobbying by civil rights groups; federal agencies have partnered with a digital health company to create an at-home test-to-treat program for flu and COVID-19.
pediatric patient
December 6th 2023

CDC Reports Higher Mortality, Treatment Interruption Rates Among Children With HIV Receiving ART vs Older Patients

Brooke McCormick
The researchers suggested prioritizing and optimizing HIV and general health services for children younger than age 5 living with HIV and receiving ART to help address their disproportionately poorer outcomes.
Contributor: Reflections on World AIDS Day 2023—A Call to Increase Research Funding on HIV and Aging
December 1st 2023

Contributor: Reflections on World AIDS Day 2023—A Call to Increase Research Funding on HIV and Aging

Kristen D. Krause, PhD, MPH
Research on HIV and aging should be the focus of future research as World AIDS Day brings the chronic illness to the forefront.
Estimating Hidden Populations of HIV With an Advanced Capture-Recapture Model
November 23rd 2023

Estimating Hidden Populations of HIV With an Advanced Capture-Recapture Model

Julia Bonavitacola
The Targeted Minimum Loss-based Estimation proved the most accurate capture-recapture model in estimating hidden populations of patients with HIV.
Nivolumab Safe in Patients With HIV, Cancer Using ART
November 15th 2023

Nivolumab Safe in Patients With HIV, Cancer Using ART

Julia Bonavitacola
Patients who have HIV and are using antiretroviral therapy (ART) did not have adverse outcomes when using nivolumab for cancer treatment.
Human brain digital illustration. Electrical activity, flashes and lightning on a blue background. | Image credit: Siarhei - stock.adobe.com
November 14th 2023

HIV Infection Could Affect Individual’s IQ Score

Julia Bonavitacola
IQ score could be detrimentally influenced by an individual’s HIV infection, both through neurons and the gut.
Preterm Infants Show No Increase in HIV Acquisition vs Full-Term Infants Exposed in Utero
November 10th 2023

Preterm Infants Show No Increase in HIV Acquisition vs Full-Term Infants Exposed in Utero

Julia Bonavitacola
Compared with infants born at term, infants born preterm following exposure to HIV had no observed increase in acquisition of HIV.
PrEP Training During Residency Increased Knowledge of HIV
November 10th 2023

PrEP Training During Residency Increased Knowledge of HIV

Julia Bonavitacola
Residents grew more knowledgeable and more comfortable with using pre-exposure prophylaxis (PrEP) drugs for prevention against HIV after training was included in their residency program.
What We’re Reading: Free HIV Medication; MA Anticompetitive Regulations; Surge in Syphilis Cases
November 8th 2023

What We’re Reading: Free HIV Medication; MA Anticompetitive Regulations; Surge in Syphilis Cases

AJMC Staff
Medicare may cover full cost of preexposure prophylaxis drugs; rules aim to prevent excessive compensation in Medicare Advantage (MA) market; health officials advocate for widespread syphilis testing and intervention.
Conversation, mother with daughter talking on sofa and living room in their home | Image credit: Laflor/peopleimages.com - stock.adobe.com
November 4th 2023

Stigma Could Affect Mothers Disclosing HIV Status to Children

Julia Bonavitacola
Mothers in the United States were surveyed about the time of disclosure of their HIV status to their children, with internalized stigma of HIV a significantly associated factor.
Intervention Increases HIV Testing Uptake in Men, Study Finds
November 1st 2023

Intervention Increases HIV Testing Uptake in Men, Study Finds

Julia Bonavitacola
Men who had sex with men had increased HIV testing after participating in an intervention.
Highly Active ART Treatment Improved Immunohematological Profile
October 28th 2023

Highly Active ART Treatment Improved Immunohematological Profile

Julia Bonavitacola
Patients with HIV who started highly active antiretroviral therapy (ART) for 6 months had an improved immunohematological profile by the end of the study.
Telehealth Well Received With Satisfaction in Patients Living With HIV
October 25th 2023

Telehealth Well Received With Satisfaction in Patients Living With HIV

Julia Bonavitacola
Patients living with HIV had an interest in future use of telehealth due to high satisfaction in the care provided.
<123456789
...
32>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo